ANO5‐muscular dystrophy: clinical, pathological and molecular findings
- 12 May 2013
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 20 (10), 1383-1389
- https://doi.org/10.1111/ene.12191
Abstract
Background and purpose Anoctamin 5 (ANO5) is a putative intracellular calcium-activated chloride channel. Recessive mutations in ANO5 cause primary skeletal muscle disorders (limb-girdle muscular dystrophy 2L and distal muscular dystrophy), which are phenotypically similar to dysferlinopathy, a muscular dystrophy due to dysferlin-encoding gene (DYSF) mutations. Methods This study reports the phenotype and genotype of seven unrelated patients with ANO5-muscular dystrophy. Results Three patients had amyloid deposition in muscle and two had cardiac involvement. An additional patient without skeletal muscle amyloidosis had cardiac involvement with septal hypokinesis and supraventricular tachycardia requiring ablation. Amyloid subtyping using laser capture microdissection and mass spectrometry-based proteomic analysis did not identify ANO5 or any fragment of ANO5 in the amyloid deposits, but detected other known amyloidogenic proteins. Three patients had myotonic discharges without clinical myotonia. Four ANO5 mutations are novel, including a heterozygous 0.4 Mb deletion involving the entire ANO5 gene. Conclusions The results of the present study suggest that ANO5 mutations can be associated with amyloid deposition in muscle, but the nature of the amyloid deposits remains indeterminate, as does their relationship with cardiac involvement. ANO5 analysis should be considered in cases of muscle amyloid deposition of indeterminate etiology. Electrical myotonia can accompany ANO5-muscular dystrophy.This publication has 17 references indexed in Scilit:
- Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patientsNeuromuscular Disorders, 2012
- Myopathy caused by anoctamin 5 mutations and necrotizing vasculitisZeitschrift für Neurologie, 2012
- Novel ANO5 mutations causing hyper‐CK‐emia, limb girdle muscular weakness and miyoshi type of muscular dystrophyMuscle & Nerve, 2012
- Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5Neurology, 2012
- Miyoshi-like distal myopathy with mutations in anoctamin 5 geneRevue Neurologique, 2012
- ANOs 3–7 in the anoctamin/Tmem16 Cl− channel family are intracellular proteinsAmerican Journal of Physiology-Cell Physiology, 2012
- Amyloidosis and exercise intolerance in ANO5 muscular dystrophyNeuromuscular Disorders, 2012
- A new distal myopathy with mutation in anoctamin 5Neuromuscular Disorders, 2010
- A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophyBrain, 2010
- Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular DystrophiesAmerican Journal of Human Genetics, 2010